Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Gabapentin
United Therapeutics Europe Ltd
Peripheral Nerve Disorder Associated With Repair of Hernia
1 trial -
Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
The George Institute
Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV
1 trial -
Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
Pierre Fabre Australia Pty Ltd
giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral
1 trial -
Glucagon-like peptide-1 receptor agonist:Semaglutide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Glycopyrronium in Combination With Tropisetron
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
Group A (the standard 2HRZE/4HR regimen)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
1 trial -
HTX-011
Heron Therapeutics
Analgesia
6 trials -
HTX-011
Heron Therapeutics
Postoperative Pain
8 trials -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.
The George Institute
Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).
1 trial -
HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE
The George Institute
Rheumatoid Arthritis
1 trial -
Haloperidol
United Therapeutics Europe Ltd
Migraine Headaches
1 trial -
Heliox inspirate
United Therapeutics Europe Ltd
Work of Breathing
1 trial -
Henagliflozin Proline Tablets treatment
The First People's Hospital of Lianyungang
Diabetes Type 2
1 trial -
Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient
Biocodex
Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))
1 trial -
Hidrathea 9 mg/ml colirio en solución, Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución
Wuhan Createrna Science and Technology Co., Ltd
Dry Eye Disease
1 trial -
High-dose anrikefon
The First People's Hospital of Lianyungang
Laparoscopic Surgery
2 trials -
Honghe Fujie lotion
The First People's Hospital of Lianyungang
Bacterial Vaginitis
1 trial -
Hydroxychloroquine Sulfate
The First People's Hospital of Lianyungang
Primary IgA Nephropathy
1 trial -
Hydroxychloroquine Sulfate 200 Mg Tablet
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Hylenex
HALOZYME THERAPEUTICS, INC.
Healthy
2 trials -
Hyperbaric bupivacaine+Sufentanil
Lxo Ireland Designated Activity Company
Anesthesia; Functional
1 trial -
Hypo-osmolar ORS
United Therapeutics Europe Ltd
Diarrhoea
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources